NEW YORK (GenomeWeb) – A team led by researchers at Regeneron Pharmaceuticals has uncovered a gene variant that appears to protect against chronic liver disease.
Chronic liver disease and cirrhosis affect about 3.9 million adults in the US and caused the deaths of 40,326 people in 2015, according to the Centers for Disease Control and Prevention.